Navigation Links
Veterans Honor Dr. Richard Merkin During Research Week
Date:4/24/2008

veterans with diabetes is considerably higher than the 50% amputation rate among diabetes in the general US population. It is therefore not surprising that the costs of treating diabetic patients with LE amputations have steadily increased in the VA system from 1989 to 1998 and is expected to increase unless we are able to prevent DFU.

The study is being conducted at two VA hospitals in California: the Long Beach VA and the West Hills/Northridge VA. The principal investigators at each site are Ian Gordon, M.D., Ph.D. and Aksone Nouvong, DPM.

Heritage Medical Research Institute was established to actively conduct medical research in conjunction with nonprofit hospitals. Its TRIP Program (Translating Research into Practice) aims to apply research findings into measurable improvements in patient care.

Dr. Richard Merkin is the President of Heritage Provider Network, one of the largest physician-owned multi-specialty physician groups in California. The company consists of medical groups and IPAs with 21 satellite medical facilities serving Southern/Central California and New York, comprised of 3,500 primary care physicians, 13,000 specialists, and 36 hospitals.


'/>"/>
SOURCE Dr. Richard Merkin
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Easter Seals Launches Program for Veterans Returning from Iraq and Afghanistan with Traumatic Brain Injuries
2. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
3. The Jericho Project Announces Rehabilitation Residence for Homeless and Low-Income Veterans
4. Mismanagement at North Florida/South Georgia Veterans Health System Results in Chronic Staff Shortages, Budget Issues
5. Younger Veterans at Greater Suicide Risk
6. Key findings for all veterans seen in depression and suicide study
7. Knights of Columbus to Distribute Wheelchairs to Veterans in Need
8. Chicago Bears Players Visit Hospitalized Veterans
9. Shape Shifting on Veterans Day
10. Knights to Distribute $1 Million Worth of Wheelchairs for Veterans
11. Report Release: Veterans for America Finds Care for PTSD and TBI Inadequate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...21 NursingCenter.com, the premier ...peer reviewed content, has been,updated to improv...tered,users. Powered by Lippincott Williams &...er 900 peer-reviewed continuing education activiti...han 50 leading nursing journals.,Lippincott Willi...
(Date:11/21/2008)...., Nov. 21 Today, prescr...rvention in treating 88 percent of patients suffer...ns treated for a chronic condition account for 96 ...ercent of all medical costs. A proprietary new ph...ealth Solutions, Inc. (NYSE: MHS ) significantly...
(Date:11/21/2008)...w and deadly diseaseits cause remains a mysteryswe...eming with citizens, soldiers and refugees of the ...ets filled with corpses, social order broke down. ...ice and Athens lost a third of its population. It ...beginning of the end of the Golden Age of Greece. ...
(Date:11/21/2008)...21 Symmetry Medical Inc.... products to the global orthopedic device industry...rian S. Moore, President and Chief Executive Offic...ief Financial Officer, are scheduled to present at...nce at The New York Palace Hotel on Wednesday, Dec...
Breaking Medicine News(10 mins):Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...nducted a clinical trial of administering xenon ga...afting so that such patients are safe from // the ...is procedure. The team administered xenon gas to ...monary artery bypass. This treatment could revolut...
...apped with four additional law suits, after the Li...ad failed miserably. // Orange county Superior c...he families of patients who died just waiting for ..., a patient who never received a liver. The liver...
...fecting just your gums. It can increase the risk o...elivery. // The following is the conclusion arrive...New York. Participants at the conference highligh...ng increased risk of serious illness in associatio...
...ghts into why Africans have an increased susceptib...n of the disease compared to whites. // Worldwide...licted with TB and over 2 million people die due t...ycobacterium tuberculosis. According to official s...
Other Medicine News:Health News:Xenon Could Limit Nerve Damage After Stroke 2Health News:Unhealthy Gums Increase Risk Of Premature Delivery 2Health News:Vitamin D May Help In Fight Against Tuberculosis 2
(Date:11/21/2008)...nd, November 21 , ...mmittee for Medicinal Products for Human Use (CHMP... the approval of Enbrel(R),(etanercept) as a trea...escents with severe plaque psoriasis. If approved ...ee,s recommendation, Enbrel will become the,first...
(Date:11/20/2008)... , PHILADELPHIA, Nov. 20 /PRNewswire-FirstCall... that the United States Food and Drug Administrati...(R) (eltrombopag) for the treatment of thrombocyto... thrombocytopenic purpura (ITP) who have had an in...ulins or splenectomy. The approval is a significan...
(Date:11/20/2008)... Nov. 20 Duska Therapeut...today that it has submitted its,pivotal Phase 3 A...pecial,Protocol Assessment (SPA) procedure with t... Subject to securing an agreement with the FDA,... double-blind, placebo-controlled and randomized P...
(Date:11/19/2008)...v. 19 Posit Science Corporation,r...ociety for Neuroscience,Annual Conference in Wash...aining may benefit Baby Boomers. The computerized...) uses adaptive exercises that target auditory and... drive generalized,improvements in cognition by i...
Breaking Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Immigrants From India Pakistan Face U S Prostate Breast Cancer Risks 2974 1Immigrants From India Pakistan Face U S Prostate Breast Cancer Risks 2974 2Extra payments to Medicare Advantage plans to total 248 5 billion in 2008 26084 1Extra payments to Medicare Advantage plans to total 248 5 billion in 2008 26084 2ISU researchers help map first plant parasitic nematode genome sequence 4736 1ISU researchers help map first plant parasitic nematode genome sequence 4736 2Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 1Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 2Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 3Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 4
...March 8, 2007--The World Health Organization,has r... rising in,Pakistan. , So is this another instance...armaceutical industry is denying important vaccine...rding to London’s Guardian,newspaper, &ldquo...efused to allow health workers to administer polio...
...USINESS WIRE)--Mar 8, 2007 - Magen BioSciences,In...ed the,publication of a paper in the March 9, 2007...oard member, David E. Fisher, M.D.,Ph.D., that id...n,p53, in the pigmentation of skin. Fisher,s stud...r suppressor in other cancers in,the body, p53 als...
Other Medicine Technology:Why Is Polio Spreading in Pakistan? 2Study in Cell by Magen BioSciences Co-Founder David E. Fisher,Identifies New Roles in Skin Cancer Prevention for Key Tumor,Suppressor Protein 2
...est addition to the Primus family of fine products...speed and accuracy in a flexible unit ideal for lo...nutes using proven accurate boronate affinity tech... comes equipped with simple, menu-driven software,...
...poration launched the first generation HPLC system...ught a new level of automation to HPLC and placed ...n. Now in the United States, Tosohs seventh genera...able HbA1c results in 2.2 minutes, -thalassemia te...
Micromat II Hemoglobin A1c instrument is an easy-to-use, accurate and precise instrument with an requirement of only 10 L of capillary or venous sample.
The sole coagulation analyzer in the world that uses a unique dry reagent card.
Medicine Products: